{"generic":"Fosfomycin Tromethamine","drugs":["Fosfomycin Tromethamine","Monurol"],"mono":{"0":{"id":"jt4ts0","title":"Generic Names","mono":"Fosfomycin Tromethamine"},"1":{"id":"jt4ts1","title":"Dosing and Indications","sub":{"0":{"id":"jt4ts1b4","title":"Adult Dosing","mono":"<b>Uncomplicated urinary tract infection, In women:<\/b> a single 3 g dose mixed in 3 to 4 oz of water ORALLY with or without food "},"3":{"id":"jt4ts1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Uncomplicated urinary tract infection, In women<br\/>"}}},"3":{"id":"jt4ts3","title":"Contraindications\/Warnings","sub":[{"id":"jt4ts3b9","title":"Contraindications","mono":"hypersensitivity to fosfomycin tromethamine <br\/>"},{"id":"jt4ts3b10","title":"Precautions","mono":"<ul><li>bacterial overgrowth; risk of Clostridium difficile-associated diarrhea<\/li><li>using more than one dose per acute cystitis episode; increased risk of adverse events<\/li><\/ul>"},{"id":"jt4ts3b11","title":"Pregnancy Category","mono":"Fosfomycin: B (FDA)<br\/>"},{"id":"jt4ts3b12","title":"Breast Feeding","mono":"Fosfomycin: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"jt4ts5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Diarrhea (9% to 10.4%), Nausea (4.1% to 5.2%)<\/li><li><b>Musculoskeletal:<\/b>Backache (3%)<\/li><li><b>Neurologic:<\/b>Headache (3.9% to 10.3%)<\/li><li><b>Reproductive:<\/b>Dysmenorrhea (2.6%)<\/li><li><b>Respiratory:<\/b>Pharyngitis (2.5%), Rhinitis (4.5%)<\/li><li><b>Other:<\/b>Pain (2.2%)<\/li><\/ul><b>Serious<\/b><ul><li><b>Hematologic:<\/b>Aplastic anemia (rare)<\/li><li><b>Hepatic:<\/b>Cholestatic jaundice syndrome (rare), Hepatic necrosis (rare), Toxic megacolon (rare)<\/li><li><b>Other:<\/b>Angioedema (rare)<\/li><\/ul>"},"6":{"id":"jt4ts6","title":"Drug Name Info","sub":{"0":{"id":"jt4ts6b17","title":"US Trade Names","mono":"Monurol<br\/>"},"2":{"id":"jt4ts6b19","title":"Class","mono":"Antibiotic<br\/>"},"3":{"id":"jt4ts6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"jt4ts6b21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"jt4ts7","title":"Mechanism Of Action","mono":" Fosfomycin inactivates enolpyruvyl transferase, which irreversibly blocks the condensation of uridine diphosphate- N-acetylglucosamine with phosphoenopyruvate, and inhibits bacterial cell wall synthesis. Fosfomycin also decreases the adherence of bacteria to epithelial cells of the urinary tract.<br\/>"},"8":{"id":"jt4ts8","title":"Pharmacokinetics","sub":{"0":{"id":"jt4ts8b23","title":"Absorption","mono":"<ul><li> Bioavailability: 37% (fasting); 30% (food)<\/li><li>Effect of food: none<\/li><\/ul>"},"1":{"id":"jt4ts8b24","title":"Distribution","mono":"<ul><li>Protein binding: absent<\/li><li> Vd: 136.1  plus or minus  44.1 L<\/li><\/ul>"},"3":{"id":"jt4ts8b26","title":"Excretion","mono":"<ul><li>Fecal: 18%<\/li><li>Renal: 38%<\/li><li>Dialyzable: yes (hemodialysis)<\/li><\/ul>"},"4":{"id":"jt4ts8b27","title":"Elimination Half Life","mono":"Oral, 5.7  plus or minus  2.8 h <br\/>"}}},"9":{"id":"jt4ts9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>pour sachet contents into 3 to 4 ounces of water and stir; do not use hot water<\/li><li>administer immediately after dissolving in water<\/li><li>take with or without food<\/li><\/ul>"},"10":{"id":"jt4ts10","title":"Monitoring","mono":"<ul><li>CBC<\/li><li>fever<\/li><li>symptomatic improvement<\/li><\/ul>"},"11":{"id":"jt4ts11","title":"How Supplied","mono":"<b>Monurol<\/b><br\/>Oral Powder for Solution: 3 GM<br\/>"},"13":{"id":"jt4ts13","title":"Clinical Teaching","mono":"<ul><li>Drug may cause headaches, dizziness, diarrhea, nausea, stomach pain, dyspepsia, back pain, asthenia, or rash.<\/li><li>Advise patient to immediately report signs\/symptoms of Clostridium difficile-associated diarrhea (severe, watery, or bloody diarrhea).<\/li><li>Instruct patient to mix drug with water (not hot) before ingesting and to not ingest in dry form.<\/li><\/ul>"}}}